VGI Health Technology (XNEC:VTL) EPS (Diluted) : A$ (TTM As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology EPS (Diluted)?

VGI Health Technology's Earnings per Share (Diluted) for the six months ended in . 20 was A$0.00.

VGI Health Technology's EPS (Basic) for the six months ended in . 20 was A$0.00.

VGI Health Technology's EPS without NRI for the six months ended in . 20 was A$0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

VGI Health Technology EPS (Diluted) Historical Data

The historical data trend for VGI Health Technology's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology EPS (Diluted) Chart

VGI Health Technology Annual Data

Trend

EPS (Diluted)

VGI Health Technology Semi-Annual Data

EPS (Diluted)

Competitive Comparison of VGI Health Technology's EPS (Diluted)

For the Biotechnology subindustry, VGI Health Technology's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VGI Health Technology's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VGI Health Technology's PE Ratio distribution charts can be found below:

* The bar in red indicates where VGI Health Technology's PE Ratio falls into.

VGI Health Technology EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

VGI Health Technology's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(	-	)	/	0
	=

VGI Health Technology's Diluted EPS for the quarter that ended in . 20 is calculated as

Diluted EPS (Q: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(	-	)	/	0
	=

VGI Health Technology (XNEC:VTL) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

VGI Health Technology EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

VGI Health Technology (XNEC:VTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003

Website

https://www.vgiht.com

VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines